Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Validation of olfactory deficit as a biomarker of Alzheimer disease.

Woodward MR, Amrutkar CV, Shah HC, Benedict RH, Rajakrishnan S, Doody RS, Yan L, Szigeti K.

Neurol Clin Pract. 2017 Feb;7(1):5-14. doi: 10.1212/CPJ.0000000000000293.

PMID:
28243501
2.

Comparing Variability, Severity, and Persistence of Depressive Symptoms as Predictors of Future Stroke Risk.

Zahodne LB, Gilsanz P, Glymour MM, Gibbons LE, Brewster P, Hamilton J, Mez J, Marden JR, Nho K, Larson EB, Crane PK, Gross AL.

Am J Geriatr Psychiatry. 2017 Feb;25(2):120-128. doi: 10.1016/j.jagp.2016.10.009.

PMID:
27866734
3.

Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.

Mez J, Chung J, Jun G, Kriegel J, Bourlas AP, Sherva R, Logue MW, Barnes LL, Bennett DA, Buxbaum JD, Byrd GS, Crane PK, Ertekin-Taner N, Evans D, Fallin MD, Foroud T, Goate A, Graff-Radford NR, Hall KS, Kamboh MI, Kukull WA, Larson EB, Manly JJ; Alzheimer's Disease Genetics Consortium., Haines JL, Mayeux R, Pericak-Vance MA, Schellenberg GD, Lunetta KL, Farrer LA.

Alzheimers Dement. 2017 Feb;13(2):119-129. doi: 10.1016/j.jalz.2016.09.002.

4.

Predicting 2-Year Risk of Developing Pneumonia in Older Adults without Dementia.

Jackson ML, Walker R, Lee S, Larson E, Dublin S.

J Am Geriatr Soc. 2016 Jul;64(7):1439-47. doi: 10.1111/jgs.14228.

PMID:
27401847
5.

Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings.

Crane PK, Gibbons LE, Dams-O'Connor K, Trittschuh E, Leverenz JB, Keene CD, Sonnen J, Montine TJ, Bennett DA, Leurgans S, Schneider JA, Larson EB.

JAMA Neurol. 2016 Sep 1;73(9):1062-9. doi: 10.1001/jamaneurol.2016.1948.

PMID:
27400367
6.

Health Problems Precede Traumatic Brain Injury in Older Adults.

Dams-O'Connor K, Gibbons LE, Landau A, Larson EB, Crane PK.

J Am Geriatr Soc. 2016 Apr;64(4):844-8. doi: 10.1111/jgs.14014.

PMID:
26925541
7.

Anesthesia Exposure and Risk of Dementia and Alzheimer's Disease: A Prospective Study.

Aiello Bowles EJ, Larson EB, Pong RP, Walker RL, Anderson ML, Yu O, Gray SL, Crane PK, Dublin S.

J Am Geriatr Soc. 2016 Mar;64(3):602-7. doi: 10.1111/jgs.14024.

8.

Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.

Gray SL, Dublin S, Yu O, Walker R, Anderson M, Hubbard RA, Crane PK, Larson EB.

BMJ. 2016 Feb 2;352:i90. doi: 10.1136/bmj.i90.

9.

A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.

Steenland K, Goldstein FC, Levey A, Wharton W.

J Alzheimers Dis. 2016;50(1):71-6. doi: 10.3233/JAD-150778.

10.

Importance of home study visit capacity in dementia studies.

Crane PK, Gibbons LE, McCurry SM, McCormick W, Bowen JD, Sonnen J, Keene CD, Grabowski T, Montine TJ, Larson EB.

Alzheimers Dement. 2016 Apr;12(4):419-26. doi: 10.1016/j.jalz.2015.10.007.

PMID:
26602628
11.

Association between dental amalgam fillings and Alzheimer's disease: a population-based cross-sectional study in Taiwan.

Sun YH, Nfor ON, Huang JY, Liaw YP.

Alzheimers Res Ther. 2015 Nov 12;7(1):65. doi: 10.1186/s13195-015-0150-1.

12.

The Vallecas Project: A Cohort to Identify Early Markers and Mechanisms of Alzheimer's Disease.

Olazarán J, Valentí M, Frades B, Zea-Sevilla MA, Ávila-Villanueva M, Fernández-Blázquez MÁ, Calero M, Dobato JL, Hernández-Tamames JA, León-Salas B, Agüera-Ortiz L, López-Álvarez J, Larrañaga P, Bielza C, Álvarez-Linera J, Martínez-Martín P.

Front Aging Neurosci. 2015 Sep 30;7:181. doi: 10.3389/fnagi.2015.00181.

13.

Physical Function and Disability After Acute Care and Critical Illness Hospitalizations in a Prospective Cohort of Older Adults.

Ehlenbach WJ, Larson EB, Curtis JR, Hough CL.

J Am Geriatr Soc. 2015 Oct;63(10):2061-9. doi: 10.1111/jgs.13663.

14.

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease.

Lalli MA, Bettcher BM, Arcila ML, Garcia G, Guzman C, Madrigal L, Ramirez L, Acosta-Uribe J, Baena A, Wojta KJ, Coppola G, Fitch R, de Both MD, Huentelman MJ, Reiman EM, Brunkow ME, Glusman G, Roach JC, Kao AW, Lopera F, Kosik KS.

Mol Psychiatry. 2015 Nov;20(11):1294-300. doi: 10.1038/mp.2015.131.

15.

Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study.

Dublin S, Walker RL, Gray SL, Hubbard RA, Anderson ML, Yu O, Crane PK, Larson EB.

J Am Geriatr Soc. 2015 Aug;63(8):1519-26. doi: 10.1111/jgs.13562.

16.
17.

Alzheimer's disease progression by geographical region in a clinical trial setting.

Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J.

Alzheimers Res Ther. 2015 Jun 25;7(1):43. doi: 10.1186/s13195-015-0127-0.

18.

Does Stroke Contribute to Racial Differences in Cognitive Decline?

Levine DA, Kabeto M, Langa KM, Lisabeth LD, Rogers MA, Galecki AT.

Stroke. 2015 Jul;46(7):1897-902. doi: 10.1161/STROKEAHA.114.008156.

19.

Differences in Alzheimer disease clinical trial outcomes based on age of the participants.

Schneider LS, Kennedy RE, Wang G, Cutter GR.

Neurology. 2015 Mar 17;84(11):1121-7. doi: 10.1212/WNL.0000000000001376.

20.

Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.

Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Crane PK, Larson EB.

JAMA Intern Med. 2015 Mar;175(3):401-7. doi: 10.1001/jamainternmed.2014.7663.

Supplemental Content

Support Center